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Background: B cell activating factor belonging to the TNF family (BAFF) is vital for B cell survival, proliferation and
activation. Evidence indicates that BAFF is systemically or locally increased in glomerulonephritis (e.g. lupus nephritis,
IgA nephropathy). However, the effect of BAFF on human mesangial cells is not known.
Methods: The impact of BAFF on the proliferation of a human mesangial cell line in vitro was investigated. The
expression of BAFF receptor (BAFF-R) and downstream signal transduction were explored. The influence of BAFF
on the expression of related genes was also studied.
Results: Our data indicated that BAFF had a proliferative effect on human mesangial cells, as supported by the
results of cell proliferation assays and the inhibited expression of the pro-apoptotic gene Bim. BAFF-R was expressed on
the cell membrane of human mesangial cells and blockade of BAFF/BAFF-R binding abrogated the proliferative effect
of BAFF on human mesangial cells. BAFF stimulation led to rapid phosphorylation of NF-κBp65, Akt and MAPK
p38 kinase in human mesangial cells, whereas it had no effect on the expression of NF-κB p100 and phosphorylation of
Erk. The phosphorylation of Akt was very sensitive to blockade of BAFF/BAFF-R ligation, although activation of MAPK p38
and NF-κBp65 was not. BAFF treatment resulted in decreased expression of BAFF-R, which implied negative feedback
regulation after its binding.
Conclusions: BAFF promoted proliferation of human mesangial cells, which was mediated via BAFF-R. The BAFF/BAFF-R
interaction triggered Akt, p65 and p38 activation, with Akt phosphorylation being tightly dependent on BAFF/BAFF-R
interaction.
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B cell activating factor belonging to the TNF family (BAFF)
is a pivotal factor for B cell survival, proliferation and mat-
uration [1, 2]. In mice, BAFF deficiency leads to an almost
complete loss of follicular and marginal zone B lympho-
cytes [3]. In contrast, mice over-expressing BAFF develop B
cell hyperplasia, excessive immunoglobulin production and
a glomerular nephritic syndrome [4]. BAFF has three
receptors: transmembrane activator and calcium
modulator cyclophilin ligand interactor (TACI), B cell
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unless otherwise stated.(BAFF-R or BR3) [5, 6]. All three receptors are type III
single transmembrane receptors, belonging to the
tumor necrosis factor (TNF) family of receptors [5].
Unlike BCMA and TACI, BAFF-R binds solely to
BAFF and BAFF/BAFF-R signaling is crucial for pri-
mary B cell survival, differentiation and homeostasis,
as demonstrated by the fact that transitional, follicular
and marginal zone B cells are all reduced in BAFF-R
mutant mice [7–9]. Upon binding to BAFF-R, BAFF
activates protein kinase B (Akt) and extracellular
signal-regulated kinase (Erk) in an IκB kinase (IKK)-1-
dependent manner in primary B cells, thereby promoting
B cell survival [10]. Notably, activation of BAFF-R recruits
TNF receptor associated factor 6 (TRAF6) and induces
activation of the phosphatidylinositol-3-kinases (PI3K)
pathway through Akt and glycogen synthase kinase 3This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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activated protein kinase (MAPK) p38 signaling is also
involved in BAFF/BAFF-R-mediated B cell chemotaxis
[12]. BAFF-R is the unique BAFF receptor for activat-
ing the non-canonical nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) signaling
pathway through the processing of p100 into the
active p52 unit in B cells [6, 10, 13, 14], although it
can also modestly activate the canonical NF-κB signaling
pathway [15].
BAFF is mainly produced by immune cells, including
monocytes, dendritic cells, neutrophils, B cells and T
cells [6]. However, non-hematopoietic cells, including
fibroblast-like synoviocytes, osteoclasts, epithelial cells,
adipocytes, astrocytes and renal cell carcinoma cells, are
also capable of expressing BAFF under certain condi-
tions [6, 16, 17]. In humans, BAFF-R is reported to be
widely expressed by all B cell subsets except for plasma
cells resident in the bone marrow [18]. The expression/
location of BAFF and BAFF-R is closely related to the
pathogenesis of nephritis [19]. Mouse models of lupus
nephritis demonstrated an elevated serum BAFF level
which was positively associated with disease severity
[20]. Furthermore, the selective blockade of BAFF pre-
vented the development of nephritis [21]. Evidence of
BAFF and BAFF-R expression by human renal cells is
scarce in the literature, although a study by Xu et al.
reported that BAFF and BAFF-R were expressed in the
renal tubular epithelial cells of patients with renal allo-
graft rejection [22].
Mesangial cells account for 30–40 % of the total glom-
erular cell population and play major roles in glomerular
mechanical architecture, ultrafiltration, matrix equilibrium,
and the biosynthesis of various factors, and they also have
immune cell-like functions [23, 24]. The lack of a single
specific marker for human glomerular mesangial cells ham-
pers the study of mesangial cells in vivo. However, glomeru-
lar mesangial cells differentiated into a human mesangial
cell line ex vivo have demonstrated significant similarities
with in vivo mesangial cell responses [25–30]. Proliferation
of mesangial cells and expansion of the matrix have been
demonstrated in many immune-mediated forms of
glomerulonephritis including lupus nephritis [31] and IgA
nephropathy [32–34]. The effect of BAFF on human
mesangial cells has never been elucidated, although it can
be secreted by infiltrating inflammatory cells during glom-
erulonephritis [35].
In this study, we investigated the proliferative effect of
BAFF on a human mesangial cell line in vitro, as well as
BAFF-mediated downstream signaling pathways and
gene expression. The expression of BAFF receptors on
a human mesangial cell line was also examined and the
effect of blocking BAFF/BAFF-R interaction on signal
transduction studied.Methods
Reagents
Major reagents included recombinant human BAFF
(310–13, Peprotech, Rocky Hill, NJ, USA);BAFF-R anti-
body for flow cytometry and western blot (14–9117,
eBioscience, San Diego, CA, USA); BAFF-R Fc chimera
(1162-BR-050, R&D Systems, Minneapolis, MN, USA);
phospho-Akt (2965) and Akt antibodies (9272, Cell Sig-
naling Technology, Danvers, MA, USA); phospho-Erk
(Thr202/Tyr204) (9106) and Erk antibodies (9102, Cell
Signaling Technology); phospho-MAPKp38 (Thr180/
Tyr182) (9211) and MAPKp38 antibodies (9212, Cell
Signaling Technology); phospho-NF-κB p65 (Ser536)
(3033) and NF-κB p65 antibodies (4764, Cell Signaling
Technology); NF-κB p100 antibody(BS1247, Bioworld,
China); Na+/K+-ATPase antibody (BS4259, Bioworld);
carboxyfluoresceinsuccinimidyl ester (CFSE) (C34554,
Life Technologies, Carlsbad, CA, USA); reverse tran-
scription (RR014A) and real-time PCR kits (DRR036A,
TAKARA, Shiga, Japan); TRIzol (15596–18) and DNaseI
(AM2235, Life Technologies); protein extraction buffer
(P0013, Beyotime, China); MTS Proliferation Assay kit
(G3582, Promega, Madison, WI, USA); and a membrane
protein extraction kit (89842, Pierce, Thermo Scientific,
Waltham, MA, USA).
Ethical statement
This study obtained approval from the ethics review
committee of the first affiliated hospital of Sun Yat-sen
University, Guangzhou, China. Written informed con-
sent was obtained from donors from whom samples
were taken for in vitro study.
Human mesangial cell culture and treatment
The immortalized human mesangial cell (HMC) line was
kindly provided by F. X. Huang (Sun Yat-Sen University,
Guangzhou, China) [36] and grown in RPMI 1640 sup-
plemented with 10 % (v/v) fetal bovine serum at 37 °C in
a 5 % CO2 incubator. Equal numbers of mesangial cells
were cultured until 50–60 % confluent and then sub-
jected to serum starvation for 4–6 h before treatment.
Recombinant human BAFF protein was added to the cell
culture at various concentrations (5–100 ng/mL) as speci-
fied in the text. In the BAFF/BAFF-R blocking experiment,
BAFF-R Fc chimera (500 ng/mL) was administrated 30 min
before BAFF treatment.
Cell proliferation assays for human mesangial cells
After serum starvation, cells were cultured in medium with
2 % FBS containing vehicle (PBS + 0.02%BSA) or variable
concentration of BAFF protein for 48 h. Cell proliferation
was measured with a MTS Proliferation Assay kit
(Promega) based on the reaction of 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophenyl)-
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Total cell numbers were also manually counted and
dead cells were excluded with eosin red staining.
For the CFSE assay, the cells were suspended at a con-
centration of 2 × 106 cells/mL and incubated with 5 μM
CFSE for 5 min at 37 °C and then subjected to extensive
washing with PBS. Afterwards, the cells were cultured
with BAFF as indicated for 48 h then analyzed by flow
cytometry. For the time course analysis of cell proliferation,
cell proliferation was measured with the MTS Proliferation
Assay kit at time points of 0, 6, 12, 24, 36, 48 and 72 h after
administration of 20 ng/mL BAFF.
Analysis of protein expression by western blot and flow
cytometry
For signal transduction, serum-starved mesangial cells
were subjected to BAFF treatment for 10 min in medium
containing 0.5 % serum. Cells were then lysed with protein
extraction buffer (20 mM Tris pH7.5, 150 mM NaCl, 1 %
Triton X-100, sodium pyrophosphate, β-glycerophosphate,
EDTA, Na3VO4) supplemented with protease inhibitor,
centrifuged and total soluble proteins collected in the
supernatant. Twenty micrograms of protein were sub-
jected to SDS-PAGE analysis, and transferred to nitro-
cellulose membranes for 1.5 h at 100 V using a Bio-Rad
transblot apparatus (Bio-Rad, Hercules, CA, USA).
After protein transfer, the membrane was blocked with
5 % nonfat dry milk powder in PBS. The membrane
was sequentially incubated with primary antibodies and
horseradish peroxidase-conjugated secondary antibody
(Thermo). Signals were visualized with an enhanced
chemiluminescent HRP substrate (Pierce).
For detecting expression of BAFF-R on the surface of
human mesangial cells, cells were incubated with pri-
mary mouse anti-BAFF-R antibody for 30 min in PBS
supplemented with 3 % FBS, followed by APC-conjugated
anti-mouse secondary antibody. Irrelevant mouse Ig at the
same concentration was used as a negative control. Sam-
ples were analyzed by flow cytometry (MoFlo, Beckman
Coulter Inc., Indianapolis, IN, USA).
For enrichment of the cell membrane fraction, 5 × 106
cells were harvested and processed using a membrane
protein extraction kit (Pierce) according to the manufac-
turer’s instructions. The membrane and cytosolic fractions
were concentrated by ultracentrifugation and subjected to
western blot analysis. Na+/K+-ATPase and Erk kinase were
employed as control membrane and cytosolic proteins
respectively.
Real-time PCR analysis
To measure the expression of BAFF receptors and other
genes in human mesangial cells, RNA was extracted from
human mesangial cells for cDNA synthesis and real-time
PCR analysis. The cDNA nucleotide sequences wereacquired in GenBank: TACI [GenBank: NM_012452.2],
BCMA [GenBank:NM_001192.2], BAFF-R [GenBank:NM_
052945.3], BAFF [GenBank:NM_001145645.2], transform-
ing growth factor-β1 (TGF-β1) [GenBank:NM_000660.4],
vascular endothelial growth factor A (VEGFA) [Gen-
Bank:NM_001025366.2], α-smooth muscle actin (α-SMA)
[GenBank:NM_001141945.1], tissue inhibitor of me-
talloproteinase-1 (TIMP-1) [GenBank: NM_003254.2],
platelet-derived growth factor beta polypeptide (PDGF-B)
[GenBank: NM_002608.2], interferon-gamma-inducible
protein 10 (IP-10) [GenBank: NM_001565.3], interlukin-6
(IL-6) [GenBank:NM_000600.3], IL-1β [GenBank:NM_000
576.2], B-cell lymphoma 2 (Bcl-2) [GenBank:NM_000633],
Bcl-2-interacting mediator of cell death (Bim) [Gen-
Bank:NM_001204106.1], B-cell lymphoma-extra-large
(Bcl-XL) [GenBank: NM_001191.2]. Primers for each
gene were designed using Primer 3.0 software and con-
firmed against non-redundant sequences in a human
cDNA sequence database. The primer sequences are as
follows, BAFF-R: Forward 5′CCCTGGACAAGGTCAT
CATT3′, Reverse 5′TCTTGGTGGTCACCAGTTCA3′;
BCMA: Forward 5′GCAGTGCTCCCAAAATGAAT3′,
Reverse 5′GTCCCAAACAGGTCCAGAGA3′; TACI: For-
ward 5′CATCTCCTGAGGGACTGCAT3′, Reverse 5′TG
GTACCTTCCCGAGTTGTC3′; BAFF: Forward 5′CGTT
CAGGGTCCAGAAGAAA3′, Reverse 5′GTCCCATGGC
GTAGGTCTTA3′; TGF-β1: Forward 5′AAGTGGACATC
AACGGGTTC3′, Reverse 5′GTCCTTGCGGAAGTCAA
TGT3′; VEGFA: Forward 5′AAGGAGGAGGGCAGAAT
CAT3′, Reverse 5′ATCTGCATGGTGATGTTGGA3′;
α-SMA: Forward 5′TTCAATGTCCCAGCCATGTA3′,
Reverse 5′GAAGGAATAGCCAC; TIMP-1: Forward 5′AA
TTCCGACCTCGTCATCAG3′, Reverse 5′TGCAGTTTT
CCAGCAATGAG3′; IP-10: Forward 5′GCTGTACCTGC
ATCAGCATT3′, Reverse 5′TTCTTGATGGCCTTCGA
TT3′; PDGF-B: Forward 5′CTTTAAGAAGGCCACGG
TGA3′, Reverse 5′CTAGGCTCCAAGGGTCTCCT3′; IL-
6: Forward 5′CCTGATCCAGTTCCTGCAGA3′, Reverse
5′CTACATTTGCCGAAGAGCCC3′; IL-1β: Forward 5′G
GTGTTCTCCATGTCCTTTGTA3′, Reverse 5′GCTGTA




G3′; Bim: Forward 5′CCCTACAGACAGAGCCACAA3′,
Reverse 5′GTCTTCGGCTGCTTGGTAAT3′.Statistical analysis
The results are expressed as the mean ± standard devi-
ation. Statistical analysis of differences between groups
was performed using an unpaired Student’s t-test. P-
values less than 0.05 were considered statistically
significant.
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BAFF stimulates human mesangial cell proliferation
To investigate whether BAFF promotes proliferation of
human mesangial cells, we cultured a human mesangial
cell line in vitro with either vehicle or BAFF (5, 20,
100 ng/mL) for 48 h. Based on the result of MTS assays,
BAFF significantly accelerated the growth of human
mesangial cells at concentrations of 20 and 100 ng/mL
(Fig. 1A). Actual cell numbers were manually counted
by microscopy with exclusion of positive eosin red-
staining cells. The results demonstrated that human
mesangial cells significantly responded to BAFF treatmentFig. 1 BAFF promotes proliferation of human mesangial cells in vitro. Equa
for 6 h and then treated with vehicle or BAFF (5, 20, 100 ng/mL) in medium c
with MTS cell proliferation kit (a) and alive cells were manually counted (b). Fo
proliferation of cells is indicated by the decline of DNA-incorporated CFSE fluo
was added into the cell culture after serum starvation. Cell proliferation was m
kit (d). Each experiment was repeated independently at least four times and sat a concentration of 20 ng/mL, with a 26 % increase in
cell numbers compared with the vehicle control. Notably,
other dosages had no significant effect (Fig. 1B). Detection
of apoptosis by staining with annexin-V and propidium
iodide was also conducted in human mesangial cells after
48 h of culture, and less than 3 % apoptosis was observed
in all tested groups (data not shown).
When using the DNA-labeling fluorescent dye CFSE
as an indicator of cell proliferation, we found that BAFF
effectively increased the proliferation of mesangial cells
at a concentration of 20 ng/mL (Fig. 1C). Furthermore,
we found that BAFF (20 ng/mL) also enhanced thel numbers of human mesangial cell were subjected to serum starvation
ontaining 2 % serum medium for 48 h. Cell proliferation was measured
r CFSE labeling, cells were incubated with CFSE before culture. The
rescence (c). For the time course assay of proliferation, BAFF (20 ng/mL)
easured at 490 nm following the instructions of the MTS cell proliferation
tatistical significance is indicated, *p < 0.05, **p < 0.01
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24 h (11.8 % increase), 32 h (9.9 % increase), and 48 h
(19.2 % increase), and that this effect became less signifi-
cant at 72 h (Fig. 1D).
BAFF binding to human mesangial cells triggers signal
transduction
To further elucidate the mechanism by which BAFF af-
fected the proliferation of mesangial cells, the signaling
pathways downstream of BAFF were investigated by
western blot. We found that BAFF stimulation led to the
rapid phosphorylation of NF-κB p65, Akt1/2/3 and MAPK
p38 within 10 min, whereas phosphorylation of Erk1/2
and expression of NF-κB p100 were not up-regulated by
BAFF treatment (Fig. 2A). BAFF (20 ng/mL) stimulated
the phosphorylation of p65, Akt and p38 1.55-, 1.90- and
1.60-fold of vehicle controls, respectively (Fig. 2B). Con-
sistent with the mesangial cell proliferation profile, the
phosphorylation of p65, Akt and p38 protein was most
significant at a BAFF concentration of 20 ng/mL, whereas
higher or lower dosages were less effective.
BAFF-R is expressed on the surface of human mesangial
cells
BAFF has three receptors: BAFF-R, TACI and BCMA.
However, evidence of their expression on the surface of
human mesangial cells is lacking. We analyzed the mRNAFig. 2 BAFF signal transduction in human mesangial cells. Human mesang
treatment (Veh, 5, 20, 100 ng/mL, indicated with the symbol (
with antibodies used as indicated (a). b This experiment was repeated inde
were normalized to GAPDH or the unphosphorylated form of the protein.
NF-κBp65; p-Akt: p-Akt/Akt; p-Erk: p-Erk/Erk; p-p38: p-p38/p38. Statistical sig
vehicle grouplevels of BAFF-R, TACI, BCMA and BAFF in a human
mesangial cell line by real-time PCR. The results dem-
onstrated that BAFF-R gene expression was present in
human mesangial cells, while the mRNA levels of
BAFF, BCMA and TACI were very low (Fig. 3A). The
expression of BAFF-R by human mesangial cells was
confirmed by flow cytometry, with 8.4 % of human
mesangial cells having positive surface staining for
BAFF-R as compared with the Ig control (Fig. 3B).
Additionally, cell fractions of membrane and cytosolic
proteins were prepared from human mesangial cells
and subjected to western blot. The results showed that
a clear band corresponding in size to BAFF-R protein
was detected in the membrane fraction of human
mesangial cell, whereas it was not detected in the cytosolic
fraction (Fig. 3C). Collectively, these results demonstrated
that BAFF-R was expressed on the surface of human
mesangial cells, although the abundance was not high.
BAFF/BAFF-R interaction is essential for the proliferative
effect of BAFF on human mesangial cell
To analyze whether the proliferative impact of BAFF on
human mesangial cells was due to the interaction of
BAFF and BAFF-R, we used a BAFF-R Fc chimera protein
to compete for the binding of BAFF. In the presence of
BAFF-R Fc chimera protein, we found the proliferative re-
sponse of human mesangial cells after exogenous BAFFial cells were subjected to serum starvation for 4 h, and then BAFF
) for 10 min. The harvested cells were lysed for western blot,
pendently at least three times and expression ratios of target proteins
Specifically, NF-κBp100: NF-κBp100/GAPDH; p-NF-κBp65: p-NF-κBp65/
nificance is indicated as *p < 0.05, **p < 0.01 as compared with the
Fig. 3 The expression of BAFF receptors by human mesangial cells. a Total RNA was extracted from human mesangial cells and analyzed for
expression of BAFF-R, TACI, BCMA and BAFF, normalized to GAPDH expression, by real-time PCR. b The presence of BAFF-R on the surface of hu-
man mesangial cells was detected with BAFF-R antibody by flow cytometry. Background signal is presented as a gray line, and BAFF-R signal is
presented as a blue line. c Cytosolic protein fraction (indicated as c) and membrane protein fraction (indicated as m) were prepared from human
mesangial cells and subjected to western blot analysis. Whole protein lysate of activated human CD19+ B cells was loaded as a positive control
for expression of BAFF-R. Na+/K+-ATPase and Erk kinase represented membrane and cytosolic proteins respectively
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experiments also showed that proliferation induced by
BAFF (20 ng/mL) was attenuated when BAFF-R Fc
chimera (500 ng/mL) competed with the cognate mem-
brane-associated BAFF-R for binding to BAFF (Fig. 4B).
Furthermore, we found that the BAFF-R Fc chimera
inhibited the phosphorylation of Akt, whereas the
phosphorylation of NF-κB p65 and MAPK p38 induced
by BAFF were less affected by the BAFF-R Fc chimera
(Fig. 4C).
The impact of BAFF on the expression of cytokines and
growth factors by human mesangial cells
To test whether BAFF influences the expression of
growth factors, proinflammatory factors, chemokines
or bioactive molecules by human mesangial cells in
addition to its proliferative effect, we analyzed the ex-
pression of VEGFA, PDGF-B, TGF-β1, IL-6, IL-1β, IP-10,
α-SMA and TIMP-1 after BAFF treatment for 30 min, 6 h
and 48 h. However, the results showed that BAFF had no
significant effect on the expression of these molecules
(Fig. 5A, B). The mRNA levels of collagen IV, iNOS, fibro-
nectin, MMP2, and MMP9 were very low as detected by
real-time PCR, with or without BAFF treatment (data not
shown). Additionally, the expression of the apoptosis-
related genes Bcl-2, Bcl-XL, and Bim was determined, and
the result indicated that the expression of the pro-
apoptotic gene Bim was significantly decreased after 6 h(21.3 % reduction) and 48 h (36.8 % reduction) of BAFF
treatment. Furthermore, BAFF stimulation decreased
BAFF-R expression after 6 h (28.9 % reduction) and 48 h
(33.6 % reduction) in human mesangial cells (Fig. 5C).
Discussion
Over-expression of BAFF has been convincingly proven
to cause autoimmune disease and glomerular nephritic
syndrome [20, 37]. Many studies found the development
of immune-mediated glomerulonephritis was mainly
due to the deposition of immune-complexes in the kid-
ney, a consequence of increased binding of BAFF to its
receptors and stimulation of B cell function [4, 38].
Additionally, the local concentration of BAFF in the
kidney is increased several fold in pathological situa-
tions, as previously shown in lupus nephritis [35, 39]
and IgA nephropathy [40]. Hence, accumulated BAFF
in renal tissue may be an important inflammatory fac-
tor mediating renal pathology. Renal BAFF protein
could be released by infiltrating immune cells [39] or
derived from the peripheral circulation [41], changing
the growth factor milieu surrounding resident mesan-
gial cells, in which endogenous BAFF expressed by
mesangial cellsis very low as indicated by our data.
Whether BAFF influences resident renal mesangial
cells was previously unclear. Our results indicated that
BAFF retained a proliferative effect on an immortal-
ized human mesangial cell line through interaction
Fig. 4 BAFF-R Fc chimera inhibits BAFF-mediated proliferation of human mesangial cells in vitro. Human mesangial cells were sequentially
subjected to serum starvation for 4–6 h, BAFF-R Fc chimera (500 ng/mL) incubation for 30 min, and finally BAFF treatment (20 ng/mL) in 2 %
serum-medium for 48 h (a, b) or 0.5 % serum-medium for 10 min (c). a The number of living cells was counted manually. b The proliferation
of cells is indicated by a decline in DNA-incorporated CFSE fluorescence. c Protein from treated cells was analyzed for expression of target
proteins by western blot
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are also very likely responsive to local BAFF protein.
We found that BAFF-R was expressed on the surface
of a human mesangial cell line in vitro. Furthermore,
BAFF treatment suppressed subsequent BAFF-R ex-
pression, which suggests a negative feedback mechan-
ism. In vivo data from lupus nephritis demonstrated
that expression of BAFF-R was not detected in innate
glomerular tissue [22]. However, the in vivo expression
profile of BAFF-R and other BAFF receptors in glom-
erulonephritis (e.g. IgA nephropathy) still requires
careful characterization.
The downstream signal transduction of BAFF in B
cells passes through several pathways including PI3K-
Akt, non-canonical and canonical NF-κB signaling
pathways. BAFF/BAFF-R interaction preferentially in-
duces alternative NF-κB pathway activation in B cells
[14, 42], although classical NF-κB signaling activation
is also partially dependent on BAFF-R [14]. In our
study, modest activation of the canonical NF-κB sig-
naling pathway was induced by BAFF as indicated by
p65 phosphorylation. Patke et al. reported that BAFF
induced Akt activation in B cells within 10 min and
this event was mediated by PI3K activation [43]. We
also found BAFF-induced Akt phosphorylation within
10 min in human mesangial cells. Although the MAPKand canonical NF-κB signaling pathways were also ac-
tivated by BAFF in our study, Akt phosphorylation
may play a major role in BAFF/BAFF-R signaling
transduction given that BAFF-Fc chimera only signifi-
cantly inhibited phosphorylation of Akt, but not NF-κB
p65 or p38. Over-expression of BCMA activates NF-κB,
Elk-1, the c-Jun and p38 in HEK293 cells [44]. Thus, it
was worth investigating whether BAFF bound to
BCMA and induced downstream NF-κB and p38 acti-
vation, considering that a trace amount of BCMA
mRNA was detected in human mesangial cells in our
study. Although sustained Erk activation is observed
in BAFF during B cell death [45], the activation of Erk
induced by BAFF in mesangial cells was not signifi-
cant. The relatively high background of Erk phosphor-
ylation during mesangial cell growth made it difficult
to verify any changes.
Growth factors, cytokines and functional molecules
are critically important for human mesangial cells to
carry out their biological functions. However, the ex-
pression of the molecules we examined (VEGFA,
PDGF-B,TGF-β1, IL-6, IL-1β, IP-10, α-SMA, TIMP-1)
was not influenced by BAFF stimulation. However,
notably, the expression of the pro-apoptotic molecule
Bim was significantly inhibited in the presence of
BAFF for 6 h or 48 h. Bim has been reported to be
Fig. 5 Regulation of gene expression by BAFF in human mesangial cells. Human mesangial cells were subjected to serum starvation for 6 h
and then BAFF treatment for 30 min, 6 h or 48 h. The mRNA levels of VEGFA, PDGF-B, TGF-β1, IL-6, IL-1β, IP-10, α-SMA, TIMP-1, Bcl-2, Bcl-XL,
Bim and BAFF-R were measured by real-time PCR. This experiment was repeated independently at least three times and representative data
are shown. *p < 0.05
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process of apoptosis [46], which is in accord with our data.
These data suggest that BAFF mainly regulates the prolifer-
ation and survival of human mesangial cells, rather than
their innate biological function. Still, increased numbers of
mesangial cells will contribute to the expansion and altered
function of the mesangium, with subsequent consequences.Conclusions
Here we found that BAFF exerted a proliferative effect
on human mesangial cells in vitro through interaction
with its unique receptor BAFF-R, which was expressed
on the surface of human mesangial cells. Downstream
signaling of BAFF/BAFF-R interaction mainly resulted in
Akt activation. The proliferative influence of BAFF on
Zheng et al. BMC Nephrology  (2015) 16:72 Page 9 of 10human mesangial cells suggests that BAFF may contribute
to the pathogenesis of glomerulonephritis.
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